Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal
Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
Read More General business news How Cambium Networks Corporation’s Nasdaq delisting reshapes investor risk, liquidity, and valuation outlook (NASDAQ: CMBM) Cambium Networks Corporation faces Nasdaq delisting. Discover what it means for liquidity, investor risk, and the company’s future path. bySoujanya RaviMarch 26, 2026